GlassScriptPhysician profile
Onkar N Singh
NPI 1740331453
$1,337.15
in general payments reported to CMS, 2019-2025
25 companies · $22.07 in 2025
The $22.07 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.44 · 2020: $103 · 2021: $256 · 2022: $316 · 2023: $381 · 2024: $172 · 2025: $22.07.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $574.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $307.66 | 2023-2025 | Veozah, Myrbetriq |
| Abbvie INC. | $256.18 | 2019-2022 | |
| Pfizer INC. | $105.31 | 2022-2024 | |
| Exeltis, USA INC. | $80.92 | 2021-2024 | Slynd |
| Myovant Sciences INC. | $61.46 | 2021-2022 | |
| Therapeuticsmd, INC. | $51.78 | 2019-2022 | |
| Aspira Women'S Health INC | $47.55 | 2023-2024 | Ova1 |
| Daiichi Sankyo INC. | $43.08 | 2020-2024 | Injectafer |
| Amag Pharmaceuticals, INC. | $36.43 | 2019 | |
| Millicent US INC | $36.19 | 2020 | |
| Coopersurgical, INC. | $30.75 | 2022-2023 | Paragard T 380a |
| Organon LLC | $30.46 | 2022 | |
| Merck Sharp & Dohme LLC | $27.56 | 2019-2020 | |
| Shield Therapeutics INC | $23.61 | 2023 | Accrufer |
| Scynexis, INC. | $23.51 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $22.96 | 2023 | Myfembree |
| Avion Pharmaceuticals | $22.95 | 2020 | |
| Mylan Pharmaceuticals INC. | $19.57 | 2021 | |
| Agile Therapeutics, INC. | $19.19 | 2021 | |
| Hologic Sales and Service, LLC | $17.83 | 2021 | |
| Mayne Pharma Commercial LLC | $16.17 | 2022 | |
| Sage Therapeutics, LLC | $15.64 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $14.10 | 2022 | |
| Evofem Biosciences, INC. | $14.05 | 2022 | |
| Allergan, INC. | $12.24 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Onkar Singh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.